Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1971 of 5804
-
500 cancer patients join quest to unlock precision medicine secrets
Knowledge-focused Recruiting nowThe Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment and prevention that considers individual variability in DNA, environment and li…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New breast cancer locator aims to reduce repeat surgeries
Knowledge-focused CompletedThis interventional, post-market, multicenter clinical investigation is designed to evaluate the performance of a custom-made medical device, "the Breast Cancer Locator (BCL)" in Subjects with non-palpable breast cancer, in Europe.
Phase: NA • Sponsor: CairnSurgical, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could ozempic help people with HIV shed pounds?
Disease control Recruiting nowThe prevalence of obesity is rising worldwide, both in low- and high-income countries, including people with HIV (PWH). Semaglutide's efficacy in achieving weight loss in obese PWH is still unexplored. The aim of this study is to assess the efficacy and safety of semaglutide in a…
Phase: NA • Sponsor: University College Dublin • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a home device spot heart trouble in childhood cancer survivors?
Diagnosis OngoingThe clinical trial compares the reproducibility and accuracy of cardiac tonometry-based portable systems that may detect early cardiac dysfunction (SphygmoCor® Xcel and Oscar 2™ ambulatory blood pressure monitor) at home and in the clinic to currently available screening tests fo…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Could a common supplement help Treatment-Resistant OCD?
Disease control OngoingThis is a randomized, double-blind, placebo-controlled study investigating N-acetylcysteine (NAC) as an augmentation therapy for individuals with treatment-resistant obsessive-compulsive disorder (TR-OCD), studied within a broader cohort of treatment-resistant Obsessive-Compulsiv…
Phase: PHASE4 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:01 UTC
-
Gut bacteria may drive Long-Term inflammation after sepsis or major trauma
Knowledge-focused Recruiting nowOral and gastrointestinal microbiome dysfunction has been demonstrated to be a culprit of various systemic dysfunctions in peripheries such as cardiovascular, nervous, endocrine and musculoskeletal systems. The topic of microbiome dysfunction after surgical intensive care admissi…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Promising cancer combo trial halted early
Disease control TerminatedThe primary objective of the study is to estimate the antitumor efficacy of nanrilkefusp alfa in combination with pembrolizumab in selected tumors.
Phase: PHASE2 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Breath of hope: drug and oxygen combo tested for ALS breathing
Symptom relief OngoingThe purpose of this research study is to determine the effects of a medication, istradefylline, in conjunction with breathing air with reduced oxygen for short periods of time (called acute intermittent hypoxia, or AIH), on breathing. This project will study breathing in people w…
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Lupus drug trial halted early: what we know
Disease control TerminatedThe purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of moderately to severely active SLE.
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a new sedative protect newborn brains during cooling?
Symptom relief CompletedManagement of neonatal pain and sedation often includes opioid therapy. A growing body of evidence suggests long-term harm associated with neonatal opioid exposure. Providing optimal sedation while neonates are undergoing therapeutic hypothermia (TH) may be beneficial but also pr…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New COVID-19 vaccine candidate enters early human testing
⭐️ VACCINE ⭐️ Completedphase I study will evaluate the safety and tolerability of GEN2-Recombinant COVID-19 Vaccine (CHO cells) in healthy people aged 18 years and older. A total of 234 subjects were enrolled, of which 126 were enrolled in the 18-59-year-old group, and were randomly assigned to receiv…
Phase: PHASE1 • Sponsor: National Vaccine and Serum Institute, China • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
Can a simple pill protect kids' kidneys? new trial aims to find out
Disease control Recruiting nowWe will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either s…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Smartphone alarms and distraction techniques could help women with bladder control problems
Disease control CompletedThis randomized controlled trial evaluated the effectiveness of bladder training supported by smartphone alarm reminders and distraction techniques in women with persistent mixed urinary incontinence who continued to experience symptoms despite completing pelvic floor muscle exer…
Phase: NA • Sponsor: Izmir Katip Celebi University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for low platelets: avatrombopag tested in japanese ITP patients
Disease control CompletedEvaluate the efficacy, safety, and PK of avatrombopag given for 26 weeks in Japanese adults with chronic immune thrombocytopenia (ITP).
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Lung washings may hold clues to cancer recurrence
Knowledge-focused Recruiting nowThe purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors contains enough vesicles to do testing that may help the researchers learn more abo…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could zapping kidney nerves tame tough blood pressure in polycystic kidney disease?
Disease control OngoingRDN-ADPKD is a prospective, randomized (1:1, central randomization), single-center, hypothesis-generating, feasibility study. The purpose of the RDN-ADPKD study is to demonstrate efficacy and document safety of renal denervation (RDN) with the Paradise System in hypertensive pati…
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for kidney cancer: experimental drug XmAb819 enters human trials
Disease control Recruiting nowThe purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinoma and to identify the minimum safe and biologically active dose and the recommen…
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New approach aims to make repeat radiation safer for cancer patients
Knowledge-focused Recruiting nowThis trial applies a uniform approach to re-irradiation for planning and diagnostic image fusion, dose summation, dose calculations, and follow up for tumor control and detailed toxicity analysis of serial Organs At Risk (OARs). Serial organs include named arteries and nerves, sp…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Virtual reality goggles could replace pills for procedure pain
Symptom relief Recruiting nowAs a part of the current rheumatological practice skills, epidural injections through the sacrococcygeal hiatus take part in the strategy for managing radicular diseases. This technical act is easily performed in an outpatient context since it is a brief procedure, performed unde…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Gut health breakthrough: probiotics show promise for lupus patients
Disease control CompletedDysbiosis, or disruption of the gut microbiota, leads to the onset of autoimmunity. Increasing data suggest that the gut microbiota is changed in various murine lupus models as well as in human systemic lupus erythematosus SLE patients. Ingestion of lactobacilli, which have immun…
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC